Paper Details

  1. Home
  2. Paper Details

A new agent for atrial fibrillation: electrophysiological properties of dronedarone.

Author: CingolaniEugenio, SinghBramah N

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Amiodarone is an effective antiarrhythmic drug, but it has significant side effects due to its high iodine content. Dronedarone is a noniodinated amiodarone congener that was developed to maintain antiarrhythmic efficacy without the side effects of amiodarone. This review discusses the electrophysiological effects of dronedarone.
Paper Details　
Original Abstract of the Article :
Although originally synthesized as an antianginal compound, amiodarone has emerged as an effective antiarrhythmic for both supraventricular and ventricular arrhythmias. Over the decades, the properties, the effectiveness, the merits as well as the shortcomings of the compound have been well establis...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1074248410377618

データ提供：米国国立医学図書館（NLM）

Dronedarone: A New Hope for Atrial Fibrillation

Atrial fibrillation (AFib), a common heart rhythm disorder, can significantly impact quality of life. This study investigates the electrophysiological properties of dronedarone, a new antiarrhythmic drug for AFib. The researchers explored the mechanisms of action of dronedarone, comparing its effects to those of amiodarone, a well-established antiarrhythmic agent. The study delves into the fascinating world of cardiac electrophysiology, offering valuable insights into the development of new therapies for AFib.

Dronedarone: A Potential Alternative to Amiodarone

The study found that dronedarone, a non-iodinated amiodarone congener, exhibits antiarrhythmic properties similar to those of amiodarone but with a reduced risk of iodine-related side effects. This finding suggests that dronedarone could offer a safer and more effective alternative to amiodarone for managing AFib. Further research is needed to fully evaluate the clinical efficacy and long-term safety of dronedarone in managing AFib.

A New Era in AFib Treatment

This study provides valuable insights into the potential of dronedarone as a new therapeutic option for AFib. The findings highlight the ongoing quest for safer and more effective treatments for this common heart rhythm disorder, offering hope for patients seeking to improve their quality of life.

Dr.Camel's Conclusion

Dronedarone emerges as a promising new player in the fight against AFib, much like a camel discovering a new and refreshing oasis in the desert. The study's findings highlight the potential of new therapies to address the challenges of heart rhythm disorders, offering hope for a healthier future.

Date :
  1. Date Completed 2011-02-28
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

21098415

DOI: Digital Object Identifier

10.1177/1074248410377618

Related Literature

Article Analysis
・Side Effects of dronedarone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.